Recombinant Human TRIP-Br2 protein (His tag N-Terminus)
Be the first to review this product! Submit a review
|
(0 Publication)
Recombinant Human TRIP-Br2 protein (His tag N-Terminus) is a Human Full Length protein, in the 1 to 314 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, Mass Spec.
View Alternative Names
KIAA0127, TRIPBR2, SERTAD2, SERTA domain-containing protein 2, Transcriptional regulator interacting with the PHD-bromodomain 2, TRIP-Br2
- SDS-PAGE
Supplier Data
SDS-PAGE - Recombinant Human TRIP-Br2 protein (His tag N-Terminus) (AB180305)
15% SDS-PAGE analysis of ab180305 (3 μg).
Reactivity data
Product details
Sequence info
Properties and storage information
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
TRIP-Br2 influences regulatory functions in metabolic tissues. It participates in complexes that manage cellular growth and energy homeostasis. By interacting with transcriptional machinery TRIP-Br2 impacts processes related to cell cycle control and adipogenesis. These actions highlight its relevance in maintaining cellular function and energy balance in organisms.
Pathways
The regulatory role of TRIP-Br2 associates it with important cellular pathways like the insulin signaling pathway and cell cycle regulation. Within these pathways TRIP-Br2 interacts with proteins such as cyclin-dependent kinases (CDKs) highlighting its involvement in cell division and growth. These associations make it an important component in controlling cellular proliferation and metabolism.
Specifications
Form
Liquid
Additional notes
ab180305 was purified by using conventional chromatography techniques
General info
Function
Acts at E2F-responsive promoters as coregulator to integrate signals provided by PHD- and/or bromodomain-containing transcription factors. May act as coactivator as well as corepressor of E2F1-TFDP1 and E2F4-TFDP1 complexes on E2F consensus binding sites, which would activate or inhibit E2F-target genes expression. Modulates fat storage by down-regulating the expression of key genes involved in adipocyte lipolysis, thermogenesis and oxidative metabolism.
Post-translational modifications
Polyubiquitinated, which promotes proteasomal degradation.
Subcellular localisation
Nucleus
Target data
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com